antioxidants - CISMeF

Preferred Label : antioxidants;

MeSH definition : Naturally occurring or synthetic substances that inhibit or retard the oxidation of a substance to which it is added. They counteract the harmful and damaging effects of oxidation in animal tissues.; Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.;

MeSH synonym : Anti-Oxidants; Anti Oxidants; Antioxidant; Anti-Oxidant; Anti Oxidant;

CISMeF synonym : effect, Anti-Oxidant; effect, antioxidant; effects, Anti-Oxidant; effects, antioxidant;

Related MeSH term : antioxidant effect; Anti-Oxidant Effect; Anti Oxidant Effect; Anti-Oxidant Effects; Anti Oxidant Effects; Antioxidant Effects; Activity, Antioxidant; Antioxidants, Endogenous; Endogenous Antioxidant; Antioxidant, Endogenous;

MeSH annotation : note entry term ANTIOXIDANT EFFECT: use only for the antioxidant effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Antioxidant;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000975;

UMLS CUI

C0003402;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antioxidants [DeCS]
- antioxidant [Artificial nutrition thesaurus concept]
- antioxidant activity [GO term]
Indexing information
- (2S)-3-(4-hydroxy-3-methoxyphenyl)-propane-1,2-diol-1-O-(6'-O-galloyl)-beta-D-glucoside [MeSH Supplementary Concept]
- (E)-1-(1-(methylthio)-1-(selenophenyl)hept-1-en-2-yl)pyrrolidin-2-one [MeSH Supplementary Concept]
- 1-(2',4'-dihydroxy-3'-methoxyphenyl)-7-(4'-methoxyphenyl)-3-heptanone [MeSH Supplementary Concept]
- 1-(3',5'-dihydroxy-4'-methoxyphenyl)-7-phenyl-3-heptanone [MeSH Supplementary Concept]
- 1-(4-methoxybenzyl)-2-(4-methoxyphenyl)-1H-benzo(d)imidazole [MeSH Supplementary Concept]
- 2',4',3-trihydroxy-3',4-dimethoxychalcone [MeSH Supplementary Concept]
- 2,2'-dithienyl diselenide [MeSH Supplementary Concept]
- 2,3-bis(4-((2-hydroxynaphthalen-2-yl)methyleneamino)phenyl)-6,13-pentacenequinone [MeSH Supplementary Concept]
- 2,4-di-tert-butylphenol [MeSH Supplementary Concept]
- 2,6-di-tert-butyl-4-(2-(1-methyl-4,4-difluoro-4-bora-3a-4a-diaza-s-indacen-3-yl)-vinyl)phenol [MeSH Supplementary Concept]
- 2-((2,6-dichlorobenzylidene)amino)-5,6-dihydro-4H-cyclopenta(b)thiophene-3-carbonitrile [MeSH Supplementary Concept]
- 2-(4'-hydroxyl)phenyl-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl [MeSH Supplementary Concept]
- 2-(5-selenocyanatopentyl)benzo(de)isoquinoline-1,3-dione [MeSH Supplementary Concept]
- 2-methoxy-4-(2-(1-methyl-4,4-difluoro-4-bora-3a-4a-diaza-s-indacen-3-yl)-vinyl)phenol [MeSH Supplementary Concept]
- 2-methyl-6-methyl-benzene-1,4-diol [MeSH Supplementary Concept]
- 3'(14'-apo-beta-carotene-14'-carbonyl)-daidzein [MeSH Supplementary Concept]
- 3'-O-methylhypolaetin-7-O-(6'''-O-acetyl-beta-D-allopyranosyl-(1-2))-6''-O-acetyl-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 3,2'-dihydroxy-4,3'-dimethoxychalcone-4'-glucoside [MeSH Supplementary Concept]
- 3-(6-(4-oxo-4H-1,3-benzothiazin-2-yl)pyridin-2-yl)propanoic acid [MeSH Supplementary Concept]
- 3-methoxyisonicotinic acid [MeSH Supplementary Concept]
- 3a.7a',7a.3a'-dihydroxyligustilide [MeSH Supplementary Concept]
- 4'-O-(2'''-O-caffeoyl)2',3',3,4-tetrahydroxychalcone [MeSH Supplementary Concept]
- 4,4'-diapolycopene-4,4'-dioic acid [MeSH Supplementary Concept]
- 4-(2-(1-methyl-4,4-difluoro-4-bora-3a-4a-diaza-s-indacen-3-yl)-vinyl)phenol [MeSH Supplementary Concept]
- 6'-O-acetylisobiflorin [MeSH Supplementary Concept]
- 6-hydroxy-3-(4'-hydroxybenzoyl)coumarin [MeSH Supplementary Concept]
- 6A,6A'-dicyclohexylamine-6B,6B'-diselenide-bis-beta-cyclodextrin [MeSH Supplementary Concept]
- 7-methylaromadendrin [MeSH Supplementary Concept]
- AEOL 10150 [MeSH Supplementary Concept]
- CDSO3 compound [MeSH Supplementary Concept]
- EUK-134 [MeSH Supplementary Concept]
- Fluvastatin [MeSH Descriptor]
- HPS4-2A polysaccharide [MeSH Supplementary Concept]
- JBIR-125 [MeSH Supplementary Concept]
- JBIR-94 [MeSH Supplementary Concept]
- M40401 [MeSH Supplementary Concept]
- MV-ONE [MeSH Supplementary Concept]
- N(9)-imidazo-(1,2)-benzimidazol [MeSH Supplementary Concept]
- N,N'-bis(salicylideneamino)ethane-manganese(II) [MeSH Supplementary Concept]
- N-(6,8-dimercaptooctanoyl)-2-aminoethanesulfonic zinc complex [MeSH Supplementary Concept]
- N-(tert-butyl)hydroxylamine [MeSH Supplementary Concept]
- N-benzylcinnamide [MeSH Supplementary Concept]
- Neu-107 [MeSH Supplementary Concept]
- Neu-164 [MeSH Supplementary Concept]
- Oligopin [MeSH Supplementary Concept]
- ac-cel compound [MeSH Supplementary Concept]
- adonirubin [MeSH Supplementary Concept]
- benzyl 2-hydroxy-4-O-beta-D-glucopyranosyl-benzoate [MeSH Supplementary Concept]
- bis(bis(N-allylbenzimidazol-2-ylmethyl)benzylamine)silver(I) [MeSH Supplementary Concept]
- calophyllic acid [MeSH Supplementary Concept]
- cratoxylumxanthone D [MeSH Supplementary Concept]
- diaqua(disalicylaldehyde ethylenediamine)chromium(III) [MeSH Supplementary Concept]
- dihydroasparagusic acid [MeSH Supplementary Concept]
- dihydrolipoyl dioleoylglycerol [MeSH Supplementary Concept]
- dimethylaniline monooxygenase (N-oxide forming) [MeSH Supplementary Concept]
- disalicylaldehyde ethylenediamine [MeSH Supplementary Concept]
- ethanone-1-C-beta-D-glucopyranoside [MeSH Supplementary Concept]
- euforia [MeSH Supplementary Concept]
- feruloylarabinose [MeSH Supplementary Concept]
- gamma-L-glutamyl-S-(2-(((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12- trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)carbonyl)-3-oxo-3-((2-sulfoethyl)amino)propyl)-L-cysteinylglycine sodium salt [MeSH Supplementary Concept]
- hydroperoxide isomerase [MeSH Supplementary Concept]
- ibuprofen hydrazide [MeSH Supplementary Concept]
- isorenieratene [MeSH Supplementary Concept]
- linderone A [MeSH Supplementary Concept]
- lodoxamide tromethamine [MeSH Supplementary Concept]
- majdine [MeSH Supplementary Concept]
- manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin [MeSH Supplementary Concept]
- mauran [MeSH Supplementary Concept]
- poliumoside [MeSH Supplementary Concept]
- poly(binaphthyl salen manganese complex) [MeSH Supplementary Concept]
- poly(vanillin oxalate) [MeSH Supplementary Concept]
- pyclen [MeSH Supplementary Concept]
- ramalin [MeSH Supplementary Concept]
- salicylidenecurcumin [MeSH Supplementary Concept]
- senecainin A [MeSH Supplementary Concept]
- tetramethylpyrazine diphenylmethyl piperazidine [MeSH Supplementary Concept]
- transdiaqua(N,N'ethylenebis (salicylideneimine)chromium(III))perchlorate [MeSH Supplementary Concept]
- tripropylene glycol [MeSH Supplementary Concept]
- uncinataflavone A [MeSH Supplementary Concept]
- zeylaniin A [MeSH Supplementary Concept]
MedlinePlus topic(s)
- antioxidants [MedlinePlus Topic]
Record concept(s)
- Antioxidant Activity [MeSH concept]
- Endogenous Antioxidants [MeSH concept]
- antioxidant effect [MeSH concept]
- antioxidants [MeSH concept]
See also
- Anticorrosives [DeCS]
- Oxidation [DeCS]
- Oxygen Radical Absorbance Capacity [MeSH Descriptor]
- Phenolic Compounds [DeCS]
- food preservatives [MeSH Descriptor]
- oxidants [MeSH Descriptor]
- oxidation-reduction [MeSH Descriptor]
- oxidative stress [MeSH Descriptor]
- pharmaceutic aids [MeSH Descriptor]
- preservatives, pharmaceutical [MeSH Descriptor]
See also inter- (CISMeF)
- senolytic [SYNODOS term]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one [MeSH Supplementary Concept]
- 2,2,5,7,8-pentamethyl-1-hydroxychroman [MeSH Supplementary Concept]
- 2,5-di-tert-butylhydroquinone [MeSH Supplementary Concept]
- 2-tert-butylhydroquinone [MeSH Supplementary Concept]
- 3,4-dihydroxyphenylethanol [MeSH Supplementary Concept]
- 3-hydroxy-1,7-bis(4-hydroxyphenyl)-6-hepten-1,5-dione [MeSH Supplementary Concept]
- 3-hydroxypyridine [MeSH Supplementary Concept]
- 4-hydroxyphenylethanol [MeSH Supplementary Concept]
- 4-methylcatechol [MeSH Supplementary Concept]
- 5-(3, 4-dydroxyl-benzylidene)-2, 2-dimethyl-1, 3-dioxane-4, 6-dione [MeSH Supplementary Concept]
- 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-1-hepten-3-one [MeSH Supplementary Concept]
- 6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) [MeSH Supplementary Concept]
- 6-O-palmitoylascorbic acid [MeSH Supplementary Concept]
- 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid [MeSH Supplementary Concept]
- 6-methyl-2-ethyl-3-hydroxypyridine [MeSH Supplementary Concept]
- 7-fluoro-1,3-diphenylisoquinoline [MeSH Supplementary Concept]
- AM 36 [MeSH Supplementary Concept]
- Actovegin [MeSH Supplementary Concept]
- BJ-1301 [MeSH Supplementary Concept]
- Carvedilol [MeSH Descriptor]
- Ethonium [MeSH Supplementary Concept]
- H290-51 [MeSH Supplementary Concept]
- Lycopene [MeSH Descriptor]
- N,N'-diphenyl-4-phenylenediamine [MeSH Supplementary Concept]
- N-isopropyl-N-phenyl-4-phenylenediamine [MeSH Supplementary Concept]
- N-monoacetylcystine [MeSH Supplementary Concept]
- POJ-U1 polysaccharide [MeSH Supplementary Concept]
- Pramipexole [MeSH Descriptor]
- Resveratrol [MeSH Descriptor]
- SUN N8075 [MeSH Supplementary Concept]
- Sul-121 [MeSH Supplementary Concept]
- TEMPO [MeSH Supplementary Concept]
- TEMPOL-H [MeSH Supplementary Concept]
- U 74389F [MeSH Supplementary Concept]
- U 74500A [MeSH Supplementary Concept]
- U 78517F [MeSH Supplementary Concept]
- acetovanillone [MeSH Supplementary Concept]
- acteoside [MeSH Supplementary Concept]
- allyl sulfide [MeSH Supplementary Concept]
- alpha-Tocopherol [MeSH Descriptor]
- alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol [MeSH Supplementary Concept]
- apolipoprotein A-IV [MeSH Supplementary Concept]
- ascorbic acid [MeSH Descriptor]
- ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination [MeSH Supplementary Concept]
- baicalein [MeSH Supplementary Concept]
- bemethyl [MeSH Supplementary Concept]
- beta-Tocopherol [MeSH Descriptor]
- bilirubin [MeSH Descriptor]
- boldine [MeSH Supplementary Concept]
- bucillamine [MeSH Supplementary Concept]
- butylated hydroxyanisole [MeSH Descriptor]
- butylated hydroxytoluene [MeSH Descriptor]
- caffeic acid [MeSH Supplementary Concept]
- calcium ascorbate [MeSH Supplementary Concept]
- canthaxanthin [MeSH Descriptor]
- carotenoids [MeSH Descriptor]
- catalase [MeSH Descriptor]
- chromous chloride [MeSH Supplementary Concept]
- corneal protein 54, bovine [MeSH Supplementary Concept]
- diallyl trisulfide [MeSH Supplementary Concept]
- dicarbine [MeSH Supplementary Concept]
- dihydrolipoic acid [MeSH Supplementary Concept]
- dimephosphon [MeSH Supplementary Concept]
- disufenton sodium [MeSH Supplementary Concept]
- droloxifene [MeSH Supplementary Concept]
- ebselen [MeSH Supplementary Concept]
- emoxypine succinate [MeSH Supplementary Concept]
- enkephalin-Leu, Ala(2)-Arg(6)- [MeSH Supplementary Concept]
- epicatechin gallate [MeSH Supplementary Concept]
- epigallocatechin gallate [MeSH Supplementary Concept]
- ergothioneine [MeSH Descriptor]
- esculetin [MeSH Supplementary Concept]
- essential 303 forte [MeSH Supplementary Concept]
- etofylline clofibrate [MeSH Supplementary Concept]
- fenozan [MeSH Supplementary Concept]
- gamma-tocopherol [MeSH Descriptor]
- glaucine [MeSH Supplementary Concept]
- grape seed extract [MeSH Descriptor]
- histidyl-proline diketopiperazine [MeSH Supplementary Concept]
- hydroquinone [MeSH Supplementary Concept]
- hypotaurine [MeSH Supplementary Concept]
- idebenone [MeSH Supplementary Concept]
- isoascorbic acid [MeSH Supplementary Concept]
- kojic acid [MeSH Supplementary Concept]
- marmelosin [MeSH Supplementary Concept]
- masoprocol [MeSH Descriptor]
- melatonin [MeSH Descriptor]
- mequinol [MeSH Supplementary Concept]
- morin [MeSH Supplementary Concept]
- mutatoxanthin [MeSH Supplementary Concept]
- nicaraven [MeSH Supplementary Concept]
- nicotinoyl-GABA [MeSH Supplementary Concept]
- nitecapone [MeSH Supplementary Concept]
- nitroxyl [MeSH Supplementary Concept]
- nobiletin [MeSH Supplementary Concept]
- oxymethacil [MeSH Supplementary Concept]
- p-tert-butyl catechol [MeSH Supplementary Concept]
- phenidone [MeSH Supplementary Concept]
- phosphatidyl-hydroxytyrosol [MeSH Supplementary Concept]
- poly(1, 8-octamethylene-citrate-co-cysteine) [MeSH Supplementary Concept]
- potassium ascorbyl tocopheryl phosphate [MeSH Supplementary Concept]
- proanthocyanidin [MeSH Supplementary Concept]
- probucol [MeSH Descriptor]
- procyanidin [MeSH Supplementary Concept]
- prolinedithiocarbamate [MeSH Supplementary Concept]
- propyl gallate [MeSH Descriptor]
- purpurogallin [MeSH Supplementary Concept]
- pycnogenols [MeSH Supplementary Concept]
- pyrogallol [MeSH Descriptor]
- pyrrolidine dithiocarbamic acid [MeSH Supplementary Concept]
- quercetin [MeSH Descriptor]
- rebamipide [MeSH Supplementary Concept]
- retinol palmitate [MeSH Supplementary Concept]
- rosmarinic acid [MeSH Supplementary Concept]
- sacchachitin [MeSH Supplementary Concept]
- salvin [MeSH Supplementary Concept]
- selenic acid [MeSH Descriptor]
- selenium [MeSH Descriptor]
- sesamin [MeSH Supplementary Concept]
- sesamol [MeSH Supplementary Concept]
- silymarin [MeSH Descriptor]
- sodium bisulfite [MeSH Supplementary Concept]
- sodium thiosulfate [MeSH Supplementary Concept]
- tempol [MeSH Supplementary Concept]
- theaflavin [MeSH Supplementary Concept]
- thiazolidine-4-carboxylic acid [MeSH Supplementary Concept]
- thioctic acid [MeSH Descriptor]
- tirilazad [MeSH Supplementary Concept]
- tocopherols [MeSH Descriptor]
- tocopherylquinone [MeSH Supplementary Concept]
- tocotrienol, alpha [MeSH Supplementary Concept]
- tocotrienols [MeSH Descriptor]
- trans-sodium crocetinate [MeSH Supplementary Concept]
- triazoloquinazoline [MeSH Supplementary Concept]
- tricetinidin [MeSH Supplementary Concept]
- tricyclodecane-9-yl-xanthogenate [MeSH Supplementary Concept]
- turmeric extract [MeSH Supplementary Concept]
- ubiquinone 9 [MeSH Supplementary Concept]
- uric acid [MeSH Descriptor]
- vanillin [MeSH Supplementary Concept]
- violuric acid [MeSH Supplementary Concept]
- vitamin E [MeSH Descriptor]
- zeta carotene [MeSH Descriptor]
- zilascorb [MeSH Supplementary Concept]
- zinc thionein [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Antioxidant [NCIt concept]
- Antioxidants [LOINC component]
- antioxidants [MedlinePlus Topic]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients